Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.
At the very top of our list is HSM Radyoloji, a renowned diagnostic center in Istanbul known for its commitment to excellence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback